TREA

98746793 - BEONEBIO

Follow

Information

  • Trademark
  • 98746793
  • Serial Number
    98746793
  • Filing Date
    September 12, 2024
    a year ago
  • Transaction Date
    July 23, 2025
    3 months ago
  • Status Date
    July 22, 2025
    3 months ago
  • Location Date
    July 22, 2025
    3 months ago
  • Status Code
    647
  • Current Location
    TMO LAW OFFICE 111
    Employee Name
    QUEEN, ESTHER
  • Attorney Docket Number
    140679600758
    Attorney Name
    Kristen Ruisi
    Law Office Assigned Location Code
    M20
  • Owners
Information
Mark Drawing Code
4
Mark Identification
BEONEBIO
Case File Statements
  • GS0401: Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
  • GS0051: Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
  • PM0001: BE ONE BIO; BE 1 BIO
  • GS0441: Telemedicine services; health care; convalescent home services; physical therapy services; health counseling; pharmacy advice, namely, pharmaceutical advice
  • GS0421: Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design
Case File Event Statements
  • 9/12/2024 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/16/2024 - a year ago
    3 - TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Type: TAEA
  • 9/16/2024 - a year ago
    2 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 1/24/2025 - 9 months ago
    4 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/12/2025 - 8 months ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/17/2025 - 8 months ago
    7 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/17/2025 - 8 months ago
    8 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/17/2025 - 8 months ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/22/2025 - 3 months ago
    12 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/22/2025 - 3 months ago
    11 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/22/2025 - 3 months ago
    9 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/22/2025 - 3 months ago
    10 - EXAMINERS AMENDMENT E-MAILED Type: GNEA